Histone Deacetylase (HDAC) Inhibitors for the Treatment of Schistosomiasis
Schistosomiasis is a major neglected parasitic disease that affects more than 240 million people worldwide and for which the control strategy consists of mass treatment with the only available drug, praziquantel. Schistosomes display morphologically distinct stages during their life cycle and the tr...
Những tác giả chính: | Ehab Ghazy, Mohamed Abdelsalam, Dina Robaa, Raymond J. Pierce, Wolfgang Sippl |
---|---|
Định dạng: | Bài viết |
Ngôn ngữ: | English |
Được phát hành: |
MDPI AG
2022-01-01
|
Loạt: | Pharmaceuticals |
Những chủ đề: | |
Truy cập trực tuyến: | https://www.mdpi.com/1424-8247/15/1/80 |
Những quyển sách tương tự
-
Computational Insights into Natural Antischistosomal Metabolites as SmHDAC8 Inhibitors: Molecular Docking, ADMET Profiling, and Molecular Dynamics Simulation
Bằng: Abdulrahim A. Alzain, et al.
Được phát hành: (2023-05-01) -
Docking, Binding Free Energy Calculations and In Vitro Characterization of Pyrazine Linked 2-Aminobenzamides as Novel Class I Histone Deacetylase (HDAC) Inhibitors
Bằng: Emre F. Bülbül, et al.
Được phát hành: (2022-04-01) -
Gene Expression Profiling of Multiple Histone Deacetylases (<i>HDAC</i>) and Its Correlation with <i>NRF2</i>-Mediated Redox Regulation in the Pathogenesis of Diabetic Foot Ulcers
Bằng: Rajan Teena, et al.
Được phát hành: (2020-10-01) -
Pathological Role of HDAC8: Cancer and Beyond
Bằng: Ji Yoon Kim, et al.
Được phát hành: (2022-10-01) -
The Structures, Functions, and Roles of Class III HDACs (Sirtuins) in Neuropsychiatric Diseases
Bằng: Robin E. Bonomi, et al.
Được phát hành: (2024-10-01)